Evaluating the Evidence for Osteobiologic Efficacy and Cost Value

John Cherf, MD, MPH, MBA

While there is considerable opportunity in the world of biologics to advance the quality of care for our patients, the rapid evolution of these technologies has led to variability in products, cost, and outcomes.